Back to Directory

ACE-031

Performance & Endurance

Myostatin inhibitor that promotes muscle growth by blocking negative regulators of muscle development.

Key Benefits

  • ✓Dramatic muscle growth potential
  • ✓Inhibits myostatin
  • ✓Increases muscle mass
  • ✓Reduces body fat

Dosing Information

Dosage Range
Research only
Frequency
Research only
Typical Duration
Not available

Detailed Protocol

Research compound. Development discontinued. Was administered via intramuscular injection in clinical trials before discontinuation.

About ACE-031

ACE-031 is a soluble form of the activin receptor type IIB that binds to myostatin and other proteins that limit muscle growth. By sequestering these proteins, it allows enhanced muscle development. Development was discontinued due to safety concerns.

Research Notes

Clinical development discontinued by Acceleron Pharma due to safety concerns including bleeding and blood vessel issues. Research compound only.

Get Peptide Research Updates

Newsletter signup

Please wait...

Thanks for signing up! You will receive an email to confirm your subscription.

Potential Side Effects

  • •Development discontinued due to safety signals
  • •Possible nosebleeds and telangiectasias observed
  • •NOT recommended

Always consult with a healthcare professional before starting any peptide therapy.